Celldex Therapeutics Inc.
CLDX | NASDAQ
$33.52
-$4.37 (-11.53%)
Sep 22, 2026, 12:35 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.5M | 7.02M | 6.88M | 2.36M | 4.65M | 7.42M |
Cost of Revenue | n/a | 163.55M | 118.01M | 82.26M | 53.31M | 42.53M |
Gross Profit | 1.5M | -156.53M | -111.13M | -79.9M | -48.66M | -35.12M |
Operating Income | -287.4M | -195.08M | -154.54M | -115.23M | -71.24M | -63.35M |
Interest Income | 28.61M | 37.22M | 13.11M | 2.91M | 505K | 2.41M |
Pretax Income | -258.8M | -157.86M | -141.43M | -112.33M | -70.74M | -60.95M |
Net Income | -258.8M | -157.86M | -141.43M | -112.33M | -70.51M | -59.78M |
Selling & General & Admin | 43.8M | 38.55M | 30.91M | 27.2M | 20.49M | 14.46M |
Research & Development | 245.1M | 163.55M | 118.01M | 82.26M | 56.81M | 40.53M |
Other Expenses | n/a | -163.55M | -105.51M | -74.12M | -54.72M | -26.75M |
Operating Expenses | 288.9M | 38.55M | 43.41M | 35.33M | 22.58M | 28.24M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 288.9M | 202.1M | 161.43M | 117.59M | 75.89M | 70.77M |
Income Tax Expense | n/a | n/a | n/a | n/a | -227K | -1.17M |
Shares Outstanding (Basic) | 66.5M | 64.4M | 48.45M | 46.89M | 42.87M | 29.64M |
Shares Outstanding (Diluted) | 66.5M | 64.4M | 48.45M | 46.89M | 42.87M | 29.64M |
EPS (Basic) | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 | -2.02 |
EPS (Diluted) | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 | -2.02 |
EBITDA | -255.42M | -154.69M | -139.03M | -104.2M | -66.08M | -45.64M |
EBIT | -258.8M | -157.86M | -142.04M | -107.1M | -69.15M | -49.57M |
Depreciation & Amortization | 3.38M | 3.18M | 3.01M | 2.9M | 3.07M | 3.93M |
Add to Watchlist
Select watchlists to add or remove CLDX